晶泰科技(02228.HK) 宣布,与尧唐上海生物科技达成AI信使核糖核酸(mRNA)药物创新研发合作,双方将聚焦mRNA药物与CAR-T疗法领域,共同建设由AI驱动的mRNA干湿实验闭环筛选平台,加快突破性疗法面世。晶泰科技指,旗下的AI预测设计“干实验”与尧唐生物的“湿实验”验证将深度融合,形成“制备-设计-验证-优化”的快速迭代闭环,从而提高mRNA药物研发的效率和成功率。针对尧唐生物提供的...
Source Link晶泰科技(02228.HK) 宣布,与尧唐上海生物科技达成AI信使核糖核酸(mRNA)药物创新研发合作,双方将聚焦mRNA药物与CAR-T疗法领域,共同建设由AI驱动的mRNA干湿实验闭环筛选平台,加快突破性疗法面世。晶泰科技指,旗下的AI预测设计“干实验”与尧唐生物的“湿实验”验证将深度融合,形成“制备-设计-验证-优化”的快速迭代闭环,从而提高mRNA药物研发的效率和成功率。针对尧唐生物提供的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.